Back to Comparisons
LDL CholesterolvsApolipoprotein B

LDL Cholesterol vs ApoB

Understanding the differences between traditional LDL cholesterol and the more advanced ApoB marker for cardiovascular risk assessment.

Aspect
LDL Cholesterol
Apolipoprotein B
What it measures
The amount of cholesterol carried by LDL particles
The number of atherogenic (plaque-forming) lipoprotein particles
What it tells you
How much cholesterol is in your LDL particles (concentration)
How many potentially harmful particles are in your blood (count)
Cardiovascular risk prediction
Good predictor of cardiovascular risk
Superior predictor - more accurately reflects actual atherogenic burden
When they may disagree
Can underestimate risk when LDL particles are small and numerous
Captures risk from all atherogenic particles including VLDL remnants
Clinical use
Standard of care - widely used for treatment decisions
Increasingly recommended, especially when LDL is discordant with risk

Key Differences

  • •ApoB counts particles; LDL measures cholesterol content
  • •One ApoB molecule exists on each atherogenic particle
  • •ApoB includes LDL, VLDL remnants, and Lp(a) - all atherogenic
  • •When LDL and ApoB disagree, ApoB better predicts risk
  • •ApoB is especially valuable when triglycerides are elevated

Why Both Matter

The distinction between LDL cholesterol and ApoB is crucial for accurate cardiovascular risk assessment. Traditional LDL-C measures the amount of cholesterol carried in LDL particles, but it doesn't tell you how many particles are carrying that cholesterol.

ApoB (Apolipoprotein B) provides a direct count of atherogenic particles. Each LDL, VLDL remnant, and Lp(a) particle has exactly one ApoB molecule on its surface. Since each particle can penetrate the artery wall and contribute to plaque formation regardless of its cholesterol content, particle number (ApoB) may be more relevant than cholesterol content (LDL-C).

This matters because LDL particle size varies. Someone with many small, dense LDL particles could have a normal LDL-C but high ApoB (and high cardiovascular risk). This "discordance" is common in metabolic syndrome, diabetes, and obesity - conditions where LDL-C often underestimates true atherogenic burden.

Many lipidologists now consider ApoB the single best marker for cardiovascular risk and recommend it as the primary treatment target. Major guidelines increasingly include ApoB, especially when: - Triglycerides are elevated (>150 mg/dL) - Metabolic syndrome or diabetes is present - LDL-C doesn't seem to match clinical risk - More precise risk stratification is needed

Learn more about

LDL Cholesterol

Measures "bad" cholesterol that can build up in your arteries.

Learn more about

Apolipoprotein B

The main protein found in LDL and other atherogenic lipoprotein particles.

Frequently Asked Questions

Should I get ApoB tested instead of LDL?
Both are valuable. LDL-C remains the standard of care, but ApoB provides additional information, especially if you have metabolic syndrome, diabetes, elevated triglycerides, or your LDL seems discordant with your overall risk.
What is a good ApoB level?
Optimal ApoB is <90 mg/dL for most people, <80 mg/dL for high-risk individuals, and <65 mg/dL for very high-risk patients. Some longevity-focused practitioners target even lower.
Why does my LDL look fine but ApoB is high?
This discordance occurs when you have many small, dense LDL particles. Each particle has less cholesterol but still contributes to atherosclerosis. Your true atherogenic burden is better reflected by the high ApoB.
Do statins lower ApoB as well as LDL?
Yes, statins reduce both LDL-C and ApoB, typically by similar percentages. ApoB can be used to track treatment response and ensure adequate particle reduction.

Track Both Markers Over Time

Upload your blood test results to BloodTrack and monitor both LDL Cholesterol and Apolipoprotein B. See how they change together over time.

Get Started FreeView More Comparisons